Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
13.33
+0.04 (0.30%)
Nov 21, 2024, 4:00 PM EST - Market closed
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for TAK.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Takeda Pharmaceutical.
Recommendation Trends
Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
TD Cowen | TD Cowen | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +50.04% | May 16, 2023 |
TD Cowen | TD Cowen | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +125.06% | Apr 4, 2023 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +50.04% | Mar 16, 2023 |
Cowen & Co. | Cowen & Co. | Hold → Buy Upgrades $21 → $24 | Hold → Buy | Upgrades | $21 → $24 | +80.05% | Jul 19, 2022 |
Cowen & Co. | Cowen & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +46.29% | Nov 1, 2019 |
Financial Forecast
Revenue This Year
4,451.79B
from 4,263.76B
Increased by 4.41%
Revenue Next Year
4,500.42B
from 4,451.79B
Increased by 1.09%
EPS This Year
77.98
from 91.16
Decreased by -14.46%
EPS Next Year
141.77
from 77.98
Increased by 81.80%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 4.9T | 4.9T | 5.0T |
Avg | 4.5T | 4.5T | 4.6T |
Low | 4.1T | 4.2T | 4.2T |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 14.1% | 9.8% | 10.5% |
Avg | 4.4% | 1.1% | 1.4% |
Low | -3.0% | -4.9% | -6.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 146.59 | 260.51 | 284.13 |
Avg | 77.98 | 141.77 | 188.34 |
Low | 44.14 | 47.04 | 45.08 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 60.8% | 234.1% | 100.4% |
Avg | -14.5% | 81.8% | 32.9% |
Low | -51.6% | -39.7% | -68.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.